2015 Lipper Award

Janus Contrarian Fund (JSVAX)

Investing Opportunistically in Non-Consensus Equity Ideas



Inception Date2/29/2000
NAV (As of 7/6/15 )$20.65
Total Net Assets (As of 5/31/15)$4.14B
Annual Expense Ratio
(As of fiscal year end 9/30/14)
GROSS 0.89%
NET 0.89%

Performance (As of 6/30/15)
1 Year-0.50%
3 Year19.05%
5 Year13.10%
10 Year8.13%
Morningstar (As of 5/31/15)
CategoryLarge Blend
Style Box

Returns quoted are past performance and do not guarantee future results; current performance may be lower or higher. Investment returns and principal value will vary; there may be a gain or loss when shares are sold. For the most recent month-end performance click here.

Net expense ratios reflect the expense waiver, if any, Janus Capital has contractually agreed to through 2/1/16.

Quarterly Commentary - Q1 2015


Signs of an improving domestic economy pushed stocks higher during the quarter.

The Fund outperformed its benchmark during the period.

We continue to see an increase in contrarian investment ideas from the number of spin-offs taking place in the market and pressure on corporate boards to run better businesses in a slower growth environment.


Daniel R. Kozlowski, CFA

Fund Manager since 2011
Industry since 1999